Home
About
Overview
Sharing Data
ORCID
Help
History (6)
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
Prognosis of patients with hepatocellular carcinoma treated solely with transcatheter arterial chemoembolization: risk factors for one-year recurrence and two-year mortality (preliminary data).
Screening for inhalational anthrax due to bioterrorism: evaluating proposed screening protocols.
The emergence of networks in human genome epidemiology: challenges and opportunities.
A preliminary diagnostic accuracy study of quantitative MRI biomarkers for differentiating parotid tumor types.
See All 6 Pages
Find People
Find Everything
Edit My Profile
My Person List (
0
)
Return to Top
Login
Username
Password